Xeris Biopharma Holdings, Inc.
XERS
Jodie situation report
Xeris Biopharma Holdings, Inc.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 15 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 4 directly disclosed connections are confirming.
- XERS's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if XERS's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind XERS
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
RGSFiling-linked namesupplierMar 2, 2026 ▾
“We have entered into a supply agreement with Regis.”
JEFJefferies Financial Group Inc.partnerNov 6, 2025 ▾
“Financing Transactions In May 2022, we entered into an Open Market Sale Agreement with Jefferies LLC, as agent, dated May 11, 2022 ("Sales Agreement") for the offering, issuance and sale of up to a maximum aggregate offering price of $75.0 million of our comm…”
Depended on by
BBNXBeta Bionics, Inc.partnerFeb 24, 2026 ▾
“Research and Development Costs In May 2024, in connection with research and development activities, we entered into an exclusive worldwide License and Collaboration Agreement with Xeris which contains a number of contractual obligations.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 1 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
XERS is currently a Follower in the organic co-movement group Healthcare & Consumer Products. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for XERS; it is not active in the latest market snapshot.